Abstract
Background: Fu Zheng Fang (FZF) is an important Chinese medicine prescription for tumor
treatment in hospitals, which has two different types, traditional Chinese medicine (TCM) decoction
pieces and TCM formula granules.
Objective: This study aimed to determine the effective composition of the drug FZF.
Methods: In this research, FZF decoction pieces and FZF formula granules were collected and their
composition, determined by HPLC-Q-Exactive Orbitrap/MS, and multivariate statistical analysis, was
applied to distinguish differential metabolite patterns between two groups.
Results: A clear cut difference in the composition of the two groups was observed. 124 differential
chemical compositions could be identified in the positive mode, while 59 differential chemical compositions
could be identified in the negative mode. The differential chemical compositions were mainly
concentrated in flavonoids, organic acids, fatty acids, amino acid compounds, and presenting different
change rules, mainly involved in two metabolic pathways; the flavonoid biosynthesis, and flavone and
flavonol biosynthesis.
Conclusion: This study provides basic information that may be of use in the formulation of the drug in
different dosages and in the examination of their efficacy.
Keywords:
Fu Zheng Fang, HPLC-Q-exactive orbitrap/MS, differential chemical compositions, TCM decoction pieces, TCM
formula granules, tumor.
Graphical Abstract
[2]
Wang, M.W. A brief discussion on Fu Zheng Fang of our hospital agreement. J. Front. Med., 2014, 23, 325.
[4]
Li, Y.H.; Wu, Z.F.; Li, Y.Y.; Li, H.T.; Yang, M. Analysis on relativity of drying process of extract and pelleting quality of Chinese materia medica formula granule based on powder properties. Chin. Tradit. Herbal Drugs, 2017, 48(10), 1930-1935.
[5]
Han, J. Comparison and analysis of free-fried Chinese herbal formula granules and traditional Chinese herbal pieces. China Continuing Med. Educ., 2018, 10(28), 142-144.
[8]
Li, C.Y.; Wang, Z.; Wang, P.; Meng, X.L. Therapeutic material basis and action mechanism of Chinese materia medica based on metabonomic technology. Chin. Tradit. Herbal Drugs, 2013, 44(7), 918-922.
[9]
LY US. Yang, S.L.; Rao, Y.; Feng, Y.L. Application of metabolomics and related technologies in research and development field of traditional Chinese medicine. Chin. J. Chin. Mater. Med., 2018, 43(21), 4182-4191.
[16]
Ameeduzzafar.; Javed, A.; Asgar, A. Development and validation of UPLC/ESI-Q-TOF-MS for carteolol in aqueous humour: Stability, stress degradation and application in pharmacokinetics of nanoformulation. Arab. J. Chem., 2017, 10(S2), S2969-S2978.
[18]
Zhou, Y.F.; Niu, M.; Fang, J.X.; Ma, Y.Q.; Cui, Y.Y.; Dong, Y.; Zhang, R.R.; Wang, J.B.; Zhang, P. [Metabonomics study on hepatoprotective effect of Schisandrae Chinensis Fructus based on UPLC-Q-TOF-MS]. Chin. J. Chin. Mater. Med.,. 2018, 43(18), 3756-3763.
[22]
Zhou, X.; Wan, J.; Wu, C.J.; Yang, J.Y. TCM formula granule study: state guo and problems. China Pharm., 2006, 17(1), 72-74.